
Latest data shows the largest indicative borrow rate increases among liquid option names include: Arbutus Biopharma (ABUS) 36.19% +33.17, Biomea Fusion (BMEA) 4.23% +2.82, Campbell Soup (CPB) 15.28% +1.36, Aries
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| CPB | Campbell Soup | 23.13 | -5.76 | -19.94% |

Latest data shows the largest indicative borrow rate increases among liquid option names include: Arbutus Biopharma (ABUS) 36.19% +33.17, Biomea Fusion (BMEA) 4.23% +2.82, Campbell Soup (CPB) 15.28% +1.36, Aries

Latest data shows the largest indicative borrow rate increases among liquid option names include: Defiance Daily Target 2x Long OKLO ETF (OKLL) 78.12% +5.10, Quantum Computing (QUBT) 16.29% +3.20, DIREXION

Campbell Soup ( ($CPB) ) has provided an announcement. On September 16, 2026, Campbell Soup Company entered into an extension agreement to its $1.85 billion five-year credit facility originally dated

Latest data shows the largest indicative borrow rate increases among liquid option names include: ProShares UltraShort Silver (ZSL) 28.69% +2.06, MiniMed Group Inc (MMED) 19.65% +2.05, Western Union (WU) 14.04%

Campbell Soup Company (($CPB)) has held its Q4 earnings call. Read on for the main highlights of the call. Campbell Soup’s latest earnings call struck a cautious but constructive tone,

Evercore ISI lowered the firm’s price target on Campbell’s (CPB) to $21 from $22 and keeps an In Line rating on the shares. Published first on TheFly – the ultimate

UBS raised the firm’s price target on Campbell’s (CPB) to $19 from $18 and keeps a Sell rating on the shares. Published first on TheFly – the ultimate source for

RBC Capital lowered the firm’s price target on Campbell’s (CPB) to $19 from $21 and keeps a Sector Perform rating on the shares. The company’s Q4 results were pressured by

Barclays lowered the firm’s price target on Campbell’s (CPB) to $18 from $19 and keeps an Underweight rating on the shares. The company has joined a growing list of packaged

Analyst Peter Galbo from Bank of America Securities reiterated a Sell rating on Campbell Soup and keeping the price target at $18.00. Peter Galbo has given his Sell rating due
| Name | Analyst | Analyst Firm | Rating | Analyst Price Target | Action | Date |
|---|---|---|---|---|---|---|
| sell | Assigned | Nov 3, 2026 | ||||
| hold | Reiterated | Oct 20, 2026 | ||||
| sell | Reiterated | Oct 8, 2026 | ||||
| hold | Reiterated | Sep 29, 2026 | ||||
| hold | Reiterated | Sep 17, 2026 | ||||
| hold | Reiterated | Sep 14, 2026 | ||||
| sell | Reiterated | Sep 10, 2026 | ||||
| hold | Reiterated | Sep 8, 2026 | ||||
| sell | Assigned | Sep 4, 2026 | ||||
| hold | Reiterated | Sep 4, 2026 |
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| Dec 9, 2026TBA | $6.90B | $0.42 | $2.56B | -0.50 | 17.26 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.